Assessment of Long-Term Pulmonary Function and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease (COPD)

被引:0
|
作者
Gabhale, Sanjay D. [1 ]
Bagrecha, Mahavir Satishchand [2 ]
Dash, Mitali [3 ]
Sheikh, Zeeshan [4 ]
Bhuvaneshwari, S. [5 ]
Imran, Rangraze [6 ]
Satheesh, Tharini [7 ]
机构
[1] Dr DY Patil Vidyapeeth, Dr DY Patil Med Coll Hosp & Res Ctr, Dept Resp Med, Pune, Maharashtra, India
[2] Dr DY Patil Med Coll Hosp & Res Ctr, Dept Pulm Med, Pune, Maharashtra, India
[3] SCB Med Coll, Dept Pathol, Cuttack, Odisha, India
[4] RD Gardi Med Coll, Ujjain, Madhya Pradesh, India
[5] KIIT Deemed Univ, Kalinga Inst Dent Sci, Bhubaneswar, Odisha, India
[6] RAK Med & Hlth Sci Univ, Dept Internal Med, Ras Al Khaymah, U Arab Emirates
[7] Dube Surg & Dent Hosp, AOMSI, Jabalpur, Madhya Pradesh, India
关键词
Chronic obstructive pulmonary disease; COPD; longitudinal research; pulmonary function; QoL; PREVENTION;
D O I
10.4103/jpbs.jpbs_252_24
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Chronic obstructive pulmonary disease (COPD) is a prevalent respiratory condition portrayed by persistent airflow limitation and correlated symptoms. Despite advances in treatment, COPD remains a significant global health burden, necessitating ongoing research to understand its long-standing impact on pulmonary function and quality of life (QoL). Methods: This longitudinal research enrolled 200 COPD and followed them over a 5-year period. Baseline assessments included spirometry to measure forced expiratory volume in one second (FEV1) and forced vital capacity (FVC), along with standardized questionnaires assessing QoL. Follow-up assessments were conducted annually, and statistical analysis was performed to examine changes in pulmonary function and QoL over time. Results: Significant declines in FEV1 and FVC were observed at each follow-up time point compared to the baseline, indicating progressive deterioration in lung function. QoL scores, as assessed by the St. George's Respiratory Questionnaire and the COPD Assessment Test, also worsened progressively over the research period. Conclusion: Current conclusions underscore the progressive nature of COPD, highlighting the importance of proactive management strategies aimed at preserving lung function and improving QoL. Early intervention and ongoing monitoring are essential in optimizing outcomes for COPD subjects and reducing the disease burden on individuals and healthcare systems.
引用
收藏
页码:S2737 / S2739
页数:3
相关论文
共 50 条
  • [31] Improved quality of life associated with long-term use of guaifenesin in a patient with chronic obstructive pulmonary disease (COPD) & stable chronic bronchitis: A case report
    Singer, Ethan
    Miller, Judi E.
    RESPIRATORY MEDICINE CASE REPORTS, 2019, 26 : 9 - 10
  • [32] Effects of pulmonary rehabilitation on quality of life in chronic obstructive pulmonary disease patients
    Moullec, Gregory
    Laurin, Catherine
    Lavoie, Kim L.
    Ninot, Gregory
    CURRENT OPINION IN PULMONARY MEDICINE, 2011, 17 (02) : 62 - 71
  • [33] In support of the term chronic obstructive pulmonary disease (COPD)
    Díez, JD
    ARCHIVOS DE BRONCONEUMOLOGIA, 2004, 40 (11): : 480 - 482
  • [34] Adherence to long-term oxygen therapy in patients with chronic obstructive pulmonary disease
    Gauthier, Amelie
    Bernard, Sarah
    Bernard, Emmanuelle
    Simard, Serge
    Maltais, Francois
    Lacasse, Yves
    CHRONIC RESPIRATORY DISEASE, 2018, 16
  • [35] Long-Term Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease with Sarcopenia
    Choi, Yong Jun
    Kim, Taehee
    Park, Hye Jung
    Cho, Jae Hwa
    Byun, Min Kwang
    LIFE-BASEL, 2023, 13 (08):
  • [36] LONG-TERM EFFECTS OF PROTRIPTYLINE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    SERIES, F
    MARC, I
    CORMIER, Y
    LAFORGE, J
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (06): : 1487 - 1490
  • [37] Inhaled corticosteroids in the long-term management of patients with chronic obstructive pulmonary disease
    Sin, DD
    Man, SFP
    DRUGS & AGING, 2003, 20 (12) : 867 - 880
  • [38] Influence of comorbidities in long-term survival of chronic obstructive pulmonary disease patients
    Eroglu, Selma Aydogan
    Gunen, Hakan
    Yakar, Halil Ibrahim
    Yildiz, Ethem
    Kavas, Murat
    Duman, Dildar
    JOURNAL OF THORACIC DISEASE, 2019, 11 (04) : 1379 - 1386
  • [39] Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy
    Blasi, Francesco
    Bonardi, Daniela
    Aliberti, Stefano
    Tarsia, Paolo
    Confalonieri, Marco
    Amir, Omar
    Carone, Mauro
    Di Marco, Fabiano
    Centanni, Stefano
    Guffanti, Enrico
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2010, 23 (03) : 200 - 207
  • [40] Inhaled Corticosteroids in the Long-Term Management of Patients with Chronic Obstructive Pulmonary Disease
    Don D. Sin
    S. F. Paul Man
    Drugs & Aging, 2003, 20 : 867 - 880